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A ldosterone is synthesized in the zona glomerulosa (ZG) of the normal adrenal gland primarily under regulation of the renin-angiotensin-aldosterone system. 1 The binding of angiotensin II to the angiotensin II type 1 receptor in the adrenal cortex triggers several intracellular signaling cascades, including protein kinase C, calcium/calmodulindependent kinases, and MAPK (mitogen-activated protein kinase). [1] [2] [3] Angiotensin II stimulation causes cytosolic Ca 2+ oscillations, which may be induced by its extrusion from endoplasmic reticulum (ER) through the IP3R (inositol 1,4,5-trisphosphate receptor) and inflow from outside the cells through Ca 2+ channels in adrenal cells. [4] [5] [6] The activation of intracellular signaling leads to aldosterone production via a series of steroidogenic enzymes, including CYP11B2 (aldosterone synthase), which catalyzes the final steps of aldosterone biosynthesis. 1 A major site of aldosterone action is in the distal tubules of the kidney, where it is responsible for sodium homeostasis, resulting in blood pressure regulation.
Primary aldosteronism (PA), which is the most common cause of endocrine hypertension, results from the autonomous or inappropriate production of aldosterone from the adrenals. 7 The rate of cardiovascular events in patients with PA is higher than in patients with essential hypertension who have similar blood pressure and risk profiles. 8, 9 PA is mainly classified into 2 subtypes: that caused by an aldosterone-producing adenoma (APA) or by bilateral idiopathic hyperaldosteronism. 7 Recently, exome-sequencing analyses demonstrated that Abstract-Aldosterone production is initiated by angiotensin II stimulation and activation of intracellular Ca 2+ signaling. In aldosterone-producing adenoma (APA) cells, the activation of intracellular Ca 2+ signaling is independent of the renin-angiotensin-aldosterone systems. The purpose of our study was to clarify molecular mechanisms of aldosterone production related to Ca 2+ signaling. Transcriptome analysis revealed that the CALN1 gene encoding calneuron 1 had the strongest correlation with CYP11B2 (aldosterone synthase) among genes encoding Ca 2+ -binding proteins in APA. CALN1 modulation and synthetic or fluorescent compounds were used for functional studies in human adrenocortical carcinoma (HAC15) cells. CALN1 expression was 4.4-fold higher in APAs than nonfunctioning adrenocortical adenomas. CALN1 expression colocalized with CYP11B2 expression as investigated using immunohistochemistry in APA and zona glomerulosa of male rats fed by a low-salt diet. CALN1 expression was detected in the endoplasmic reticulum (ER) by using GFP-fused CALN1, CellLight ER-RFP, and the corresponding antibodies. CALN1-overexpressing HAC15 cells showed increased Ca 2+ in the ER and cytosol fluorescence-based studies. Aldosterone production was potentiated in HAC15 cells by CALN1 expression, and dose-responsive inhibition with TMB-8 showed that CALN1-mediated Ca 2+ storage in ER involved sarcoendoplasmic reticulum calcium transport ATPase. The silencing of CALN1 decreased Ca 2+ in ER, and abrogated angiotensin II-or KCNJ5 T158A-mediated aldosterone production in HAC15 cells. Increased CALN1 expression in APA was associated with elevated Ca 2+ storage in ER and aldosterone overproduction. Suppression of CALN1 expression prevented angiotensin II-or KCNJ5 T158A-mediated aldosterone production in HAC15 cells, suggesting that CALN1 is a potential therapeutic target for excess aldosterone production. (Hypertension. 2018;71: 50% to 80% of APA harbored somatic mutations in KCNJ5, ATP1A1, ATP2B3, or CACNA1D. [10] [11] [12] All of these mutations directly or indirectly activate intracellular Ca 2+ signaling and CYP11B2 transcription. 6, [10] [11] [12] Therefore, the activation of intracellular Ca 2+ signaling is crucially important to produce aldosterone both in ZG and APA.
CaBP (Ca
2+
-binding proteins) play a pivotal role in the transduction of Ca 2+ signaling. 13 The binding of CaBPs with increased intracellular Ca 2+ activates effector enzymes. Most CaBPs bind Ca 2+ through the EF-hand motif, which consists of 2 alpha helices named E and F.
14 The best-known CaBP, calmodulin, is expressed ubiquitously in most organs and tissues and binds Ca 2+ through 4 EF-hand domains. The binding induces several calmodulin kinases. 15 However, as we reported previously, the calmodulin kinase inhibitor dose not completely abrogate the increase in aldosterone production via the activation of Ca 2+ signaling. 6 Additionally, intracellular Ca 2+ is stored in the ER and mitochondria, but the Ca 2+ storage machinery has not been fully elucidated in APA.
In this study, we examined the gene expression levels of other CaBPs containing the EF-hand motif in APA, using a transcriptome analysis-based approach. Our results showed that the CALN1 gene encoding calneuron 1 was one of the most highly expressed genes and had the strongest correlation with CYP11B2 in APA. Importantly, CALN1 showed the highest global Ca 2+ affinity among all neuronal calcium sensors with a K D of 180 nmol/L. 16 Therefore, we hypothesized that CALN1 plays a key role in aldosterone production in APA and the renin-angiotensin system. We demonstrated that APA and angiotensin II-stimulated cells had higher CALN1 expression and CALN1 colocalized with CYP11B2. CALN1 was located in ER, its increased expression resulted in increased stored Ca 2+ in ER, and it potentiated aldosterone production in human adrenocortical carcinoma (HAC15) cells.
Methods

Patients and Tissue Collection
The tissues of nonfunctioning adrenocortical adenoma (NFA; n=14) or APA (n=48) obtained at adrenalectomy were enrolled in this study (Table S1 in the online-only Data Supplement) and stored at −80°C until further use. First, 24 adrenal tumors, including 5 NFA and 19 APA, were examined by microarray analysis. Next, all of the tumors, including 14 NFA and 48 APA, were investigated by quantitative polymerase chain reaction. Additional details, including the diagnosis of APA and NFA, are available in the online-only Data Supplement and our previous report. 17 Our study was approved by the ethics committee of Hiroshima University, and written informed consent was obtained from all the patients.
Cell Culture and Materials
The HAC15 cell line-a subclone of the H295R a HAC15 cell 18 was provided by WE Rainey (University of Michigan). The detailed methods of cell culture were mentioned as reported previously and are provided in the online-only Data Supplement. 19 Angiotensin II and A23187, Calcium ionophore, were purchased from Sigma Aldrich Co, Ltd (St. Louis, MO). The Fluo4-AM dye (Invitrogen, Carlsbad, CA) was used to detect intracellular Ca 2+ concentration. TMB-8-an inhibitor of sarcoendoplasmic reticulum calcium transport ATPase (SERCA)-and 2-APB-an inhibitor of inositol IP 3 -were obtained from Wako (Osaka, Japan).
DNA Extraction and Genotyping
Genomic DNA from adrenal tissues and peripheral leucocytes was isolated by the DNeasy blood and tissue kit (Qiagen, Hilden, Germany) and stored at −20°C. Polymerase chain reaction-based direct sequencing for KCNJ5, ATP1A1, ATP2B3, and CACNA1D was performed as described previously.
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Lentiviral Production and Infection
Lentivirus production and infection in HAC15 cells were conducted as reported previously and online-only Data Supplement. 6 
RNA Extraction and Quantitative Polymerase Chain Reaction Assay
Total RNA extraction, reverse transcription, and quantitative polymerase chain reaction assay were performed as reported previously and online-only Data Supplement.
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Western Blot Analysis
Cell lysis, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transfer, and blots processing were performed as reported previously and are in the online-only Data Supplement.
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Intracellular Localization of CALN1
pLVSIN-N-AcGFP with CALN1 was transduced in HAC15 cells. The ER and Golgi bodies were fluorescently labeled using CellLight ER-RFP (Thermo Fisher Scientific, Waltham, MA) and CellLight Golgi-RFP (Thermo Fisher Scientific), respectively, following the manufacturer's protocol. The fluorescence was detected using the BZ-9000 fluorescence microscope (Keyence, Itasca, IL).
To investigate endogenous CALN1 expression, HAC15 cells were first incubated with CellLight ER-RFP for 24 hours. The cells were then fixed for 10 minutes in 4% paraformaldehyde, and 0.5% Triton X-100 was added to the fixed cells for 10 minutes. The primary antibody for CALN1 (Abcam, #ab117584, Cambridge, United Kingdom) and ProLong Gold Antifade Reagent with DAPI (Thermo Fisher Scientific) were then applied.
Ca
2+ Concentration in ER and Cytosol
The Ca 2+ concentration in ER was detected by CEPIA (calcium-measuring organelle-entrapped protein indicator 1). 21 pCMV R-CEPIA1er was purchased from Addgene (Cambridge, MA). Transfection was performed using Polyethylenimine 40K (Polysciences, Inc, #23966, Warrington, PA) in 70% to 80% confluent HAC15 cells. Forty-eight hours after transfection, pCDH-CALN1-MCS-EF1-Puro was infected into HAC15 cells. Forty-eight hours after the infection, the cells were incubated using DMEM/F12 with 0.1% Cosmic Calf serum for 24 hours. The medium was replaced with Hanks Balanced Salt Solution without phenol red (Wako, Osaka, Japan) for 30 minutes, and the protein was detected at an excitation wavelength of 562 nm and an emission wavelength of 641 nm in a micro plate reader (Varioskan Flash; Thermo Fisher Scientific).
After CALN1 transduction in HAC15 cells, the cells were incubated with Fluo4-AM for the detection of Ca 2+ concentration in cytosol as described previously. 
Immunohistochemistry
Rat adrenals were collected from isoflurane anesthetized rats perfused with sterile normal saline. Rat adrenals and human NFA and APA tissues were fixed in 4% buffered paraformaldehyde and embedded in paraffin. Sections of 4 μm were cut, processed, and incubated with mouse monoclonal antibodies against rat or human CYP11B2 and CALN1 (Proteintech, #11477-1-AP, Rosemont, IL) as described previously.
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Animals
Dahl salt-sensitive (SSjr) rats from the Department of Pharmacology in-house colony were housed under standard conditions, including a 12-hour light cycle at University of Mississippi Medical Center. They were fed a standard phytosteroid-controlled rat chow with 0.2% Na + (Teklad Global 16% protein rodent diet; Harlan Laboratories, Indianapolis, IN) and tap water. At 8 weeks of age, 2 groups, 4 males and 3 to 4 female rats, received the regular chow (low salt) or chow +0.9% saline to drink (high salt) for 23 days before the adrenals were obtained. All animal protocols were approved by the Institutional Animal Care and Use Committee of the GV (Sonny) Montgomery Veterans Affairs Medical Center in accordance to the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Statistical Analysis
Basic results were expressed as mean±SE of at least 3 separate experiments in which each sample was assayed in triplicate or quadruplicate, and clinical results were expressed as mean±SD. Differences between 2 groups were analyzed for statistical significance by t test, and multiple groups were analyzed by 1-way ANOVA followed by Bonferroni comparisons. The differences were considered to be significant at P<0.05. Analyses were performed using SPSS for Windows (release 24.0; SPSS, Inc, Chicago, IL).
Results
Transcriptome Analysis of Genes Related to CaBP With EF-Hand
One hundred fifty-five genes encoding CaBPs with EF-hand were compared between NFAs (n=5) and APAs (n=19), and the heat map is depicted in Figure 1A . The most highly expressed among these was VSNL1 ( Figure 1B) . A previous study has revealed that VSNL1 (visinin like 1) protects APA cells from calcium-induced apoptosis. 24 CALN1, which encodes calneuron 1, was the second highest expressed gene in the APAs and showed the strongest correlation with CYP11B2 expression ( Figure 1B) . Furthermore, we showed all differentially expressed genes and genes encoding CaBPs between APAs and NFAs in Tables S2 and S3 in the online-only Data Supplement. 
Relationship Between CALN1 and CYP11B2 Expression in Human Tissues
CYP11B2 expression was 535.1-fold higher in APAs than in NFAs (P<0.001; Figure 2A ), and CALN1 expression was in 4.4-fold greater in APAs than in NFAs (P<0.001; Figure 2B ). CALN1 mRNA expression levels were not different among APA genotypes, such as no mutation (n=16), KCNJ5 mutation (n=27), and ATP1A1 mutation (n=5; Figure 2C ). CALN1 mRNA expression had a weak-positive correlation with CYP11B2 mRNA expression in APA (r=0.310; P=0.032; Figure 2D ).
CALN1 expression was detected in APAs, but not in NFAs, and the expression seemed to be colocalized with CYP11B2 expression in APAs ( Figure 3A ). In addition, CALN1 was detected only in ZG cells in adrenal tissue adjacent to NFA ( Figure 3B ). Aldosterone-producing cell clusters which are found by foci of CYP11B2 expressing cells in addition to normal CYP11B2 expression in ZG, 25 and CALN1 expression was not only in aldosterone-producing cell clusters but also entire ZG in human ( Figure 3B ). Interestingly, CALN1 was not detected in the zona fasciculate of the adrenal tissue ( Figure 3B ). Figure 3C are representative photomicrographs of sections from a low-salt and a high-salt fed male rat adrenal. The adrenal ZG of the low-salt fed rat comprised more and larger cells, most of which were immunoreactive for CYP11B2 by immunohistochemistry. In contrast, the ZG of high-salt fed rats was narrower, comprised smaller and fewer ZG cells with only some being moderately immunoreactive for CYP11B2. Female rats generally produce slightly more ZG and zona fasciculate steroids, but they are regulated in the same was by salt consumption. 26 The expression of CALN1 was detected only in the rat adrenal ZG (Figure 3C ), as in human tissues ( Figure 3B ). CALN1 immunoreactivity faded in the inner ZG next to the transition zone comprising smaller and more densely packed cells between the ZG and zona fasciculate, and is coexpressed in cells expressing CYP11B2, also consistent with its expression the human adrenal.
CALN1 Expression in Rat Adrenal Glands
CALN1 Expression in HAC15 Cells
Infection of HAC15 cells with lentivirus carrying the KCNJ5-T158A mutation potentiated basal aldosterone production 5.8-fold over the empty lentivirus infection (data not shown). HAC15 cells expressing the KCNJ5 mutation had 1.4-fold higher CALN1 mRNA levels than control HAC15 cells (P<0.05; Figure 3E ). CALN1 expression was significantly elevated by angiotensin II stimulation in HAC15 cells (1.7-fold increase; P<0.05; Figure 3E ). Calcium ionophore, A23187, significantly stimulated CALN1 expression (1.8-fold increase; P<0.05; Figure 3E ), suggesting that increased Ca 2+ signaling upregulates CALN1 expression.
The CALN1 protein levels were detected by Western blotting in HAC15 cells harboring the KCNJ5 mutation. Interestingly, CALN1 tv1 expression was significantly increased, whereas CALN1 tv2 was attenuated by this KCNJ5 mutation ( Figure 3F ). In addition, CALN1 tv1 transduction in HAC15 cells resulted in higher CYP11B2 expression and aldosterone levels than CALN1 tv2 transduction ( Figure S1A and S1B). Hence, CALN1 tv1 transduction was used for functional analysis.
Intracellular Localization of CALN1 and Ca
2+
Storage in ER
Previous study demonstrated that intracellular localization of CALN1 was likely to be in ER or Golgi bodies. 27 We analyzed the intracellular localization of CALN1 using CellLight RFP to detect ER or Golgi in HAC15 cells transduced with pLVSIN-N-AcGFP with CALN1 ( Figure 4A ). Endogenous CALN1 expression was also visualized by staining with antibodies ( Figure 4B ). Taken together, our results confirm that CALN1 is located in ER, probably bound to the ER membrane through its tail-anchored transmembrane domain (TA domain). 28 To examine the effects of CALN1 expression on Ca 2+ levels in cytosol and ER, we used a specific dye, Fluo4-AM, and the R-CEPIA1er method, respectively. The CALN1 overexpressing cells had significantly higher Ca 2+ levels in the cytosol and ER compared with control cells (Figure 5A and 5B). Additionally, Ca 2+ in ER was significantly increased by the KCNJ5 mutation in HAC15 cells ( Figure S2 ).
Effect of CALN1 Overexpression on Aldosterone Production
Aldosterone levels in CALN1 overexpressing cells were 11.2-fold greater than those in control cells (P<0.05; Figure 5C ; Figure S1A ). In agreement with these results, CALN1 overexpressing cells had higher CYP11B2 expression than control cells (6.0-fold increase; P<0.05; Figure 5D ; Figure S1B) .
We investigated the effects of TMB-8 and 2-APB on aldosterone production in HAC15 cells overexpressing CALN1. TMB-8 showed a dose-responsive inhibition of aldosterone production mediated by angiotensin II and CALN1 in HAC15 cells ( Figure 5E ). 2-APB significantly inhibited aldosterone production in response to angiotensin II but did not suppress aldosterone production in HAC15 cells overexpressing CALN1 ( Figure 5F ).
Silencing of CALN1 Expression in HAC15 Cells
CALN1 was silenced using a lentivirus delivering shRNA-CALN1 in HAC15 cells (shCALN1 cells) and resulted in a decreased CALN1 tv1 and tv2 protein expression by 32% and 47%, respectively ( Figure 6A and 6B). shCALN1 cells had significantly less Ca 2+ in ER compared with control cells (P<0.05; Figure 6C ). The suppression of CALN1 expression significantly abrogated angiotensin II-and KCNJ5 T158A-mediated aldosterone production in HAC15 cells ( Figure 6D and 6E).
Discussion
We demonstrated that expression of CALN1 correlated strongly with that of CYP11B2 and was limited to the normal ZG of human and rat adrenal and that CALN1 colocalized with CYP11B2 in APA. CALN1 is located in ER and increases Ca 2+ in ER and cytosol in HAC15 cells. Both angiotensin II and the KCNJ5 mutation potentiated CALN1 expression, and increased CALN1 expression led to increased aldosterone production in HAC15 cells. In contrast, CALN1 suppression significantly decreased angiotensin II-or KCNJ5 mutation-mediated aldosterone production in HAC15 cells.
We are the first to clarify that CALN1 is a key molecule for the regulation of Ca 2+ storage in the ER of adrenal ZG cells. It is well known that the ER stores abundant Ca 2+ , which is released into the cytosol when a Ca 2+ signaling pathway is activated. 1 The transfer of Ca 2+ by calmodulin in cytosol has been studied well. 29 Our results on SERCA function in ER suggest that CALN1 collaborates with SERCA to transfer Ca 2+ from the cytosol to the ER in aldosterone-producing adrenal cells. CALN1 binds to ER by its TA domain and has 4 EF hands in the cytosol, which may sense cytosolic Ca
2+
. 28 Taken together with data from previous structural analysis, our results indicate that the increase in CALN1 expression provides greater opportunity to bind cytosol Ca 2+ , resulting in enhancement of the SERCA function to increase Ca 2+ storage in the ER. According to a previous study, excess Ca 2+ in ER leads to Ca 2+ efflux through IP3R without IP3 stimulation. 30 In fact, an IP3 inhibitor did not suppress the aldosterone production in HAC15 cells overexpressing CALN1 ( Figure 5F ). Taking our results together with previous reports, we postulate that increased CALN1 expression lead to the accumulation of Ca 2+ in ER via collaboration with SERCA, and the increased Ca 2+ leaking into the cytosol stimulates aldosterone production in APAs ( Figure S3 ).
CALN1 is a potential therapeutic target to mitigate excess of aldosterone production because KCNJ5 T158A-mediated aldosterone production was found to be inhibited by silencing CALN1 mRNA. Likewise, this study was performed to identify a key molecule for Ca 2+ signaling in APA and lead to our finding that CALN1 had the strongest correlation with CYP11B2 among CaBPs and was colocalized with CYP11B2 in APAs. In considering therapeutic targets of aldosterone excess, we must evaluate the adverse effects on cortisol production. In contrast to CYP11B2 inhibitors that are not totally selective, 31 CALN1 suppression is unlikely to inhibit cortisol production because it is specific to the ZG of the human and rat adrenals. Furthermore, CALN1 expression is limited to the brain and adrenal gland according to RNA-seq analysis. 32 Compounds targeting CALN1 that do not cross the blood-brain barrier might be useful to mitigate aldosterone excess.
The aldosterone production mediated by angiotensin II was also abrogated by the silencing of CALN1 in this study. Cytosolic Ca 2+ increases in response to angiotensin II stimulation with subsequent accumulation in the ER. 1 Angiotensin II also initiates IP3 signaling. Therefore, the increased Ca 2+ in ER would lead to an increase in Ca 2+ released into the cytosol by IP3 signal via angiotensin II stimulation in adrenal cells. 33 Ca 2+ storage in ER was decreased in adrenal cells in which CALN1 was silenced, reducing aldosterone production by angiotensin II stimulation. Therefore, a CALN1 antagonist would also be a selective therapeutic target in patients with renin-induced hyperaldosteronism, such as renal artery stenosis.
CALN1 expression was detected in the ZG of the human adrenal gland even where CYP11B2 was not detected by immunohistochemistry. Additionally, the adrenal ZG of rats consuming a high-salt diet, which had low plasma renin and aldosterone concentrations as expected, also had some expression of CALN1. CALN1 is basally expressed in ZG cells even when aldosterone production is low. It seems that CYP11B2 expression is regulated by CALN1 expression and Ca 2+ signaling induced by angiotensin II or a mutation driving aldosterone production, all of which, to date, cause an increase in intracellular Ca 2+ mobilization. Previous studies indicate that CALN1 has a role in the trans-Golgi network or transferring the vesicles in the Golgi bodies or ER of the brain. 27 Although we investigated the expressions of genes related with trans-Golgi network between APA and NFA, we found no differences (data not shown). This is not surprising because, unlike neurons or glia cells, secretory granules or vesicles are unremarkable in adrenocortical or other primarily steroidogenic cells. CALN1 seems to have different roles in the adrenal gland and brain.
This study has a limitation. CALN1 has 2 transcript variants, in whom the sequences are identical from exon 2 to 6, whereas exon 1 is transcribed only in tv 1. Therefore, specific primers to differentiate between the 2 variants might not be available. However, we separated them by western blotting, so a protein assay might be more useful for functional analysis compared with the mRNA assay. We showed that tv 1 was the stronger promoter of aldosterone production of between the 2 variants ( Figure 3F ; Figure S1A and S1B). Thus, we could further clarify more important roles of CALN1 function for aldosterone production.
Perspectives
Because patients with PA have an increased risk of cardiovascular and cerebrovascular complications compared with those with essential hypertension, 8, 9 all of somatic mutations which drive aldosterone production directly or indirectly activate intracellular Ca 2+ signaling and CYP11B2 transcription. 6, [10] [11] [12] The elucidation of the molecular mechanisms of aldosterone production related with Ca 2+ signaling pathway is crucially important for the development of therapeutic agents for PA. We demonstrated that CALN1 expression was enhanced in APA and after angiotensin II stimulation in HAC15 cells or ZG of rats. The increased CALN1 expression was associated with increased Ca 2+ storage in ER and cytosol, resulted in aldosterone overproduction. Suppression of CALN1 expression abrogated angiotensin II-or KCNJ5 T158A-mediated aldosterone production in HAC15 cells. CALN1 suppression is unlikely to inhibit cortisol production because it is specific to the ZG of the human and rat adrenals. Taken together, CALN1 is a potential selective therapeutic target for excess of aldosterone production in patients with APA and renininduced hyperaldosteronism.
